Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-31

Clinical Trial Update: Terbinafine Compared to Griseofulvin in Children With Tinea Capitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Terbinafine to Griseofulvin in children with tinea capitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Griseofulvin (GRISEOFULVIN)
  • Terbinafine (terbinafine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Tinea Capitis | Phase 3 | Status: COMPLETED